Skip to product information
1 of 2

WhatsApp USA: +1 6032769350 | WhatsApp HK: +852 63697831

Global Healthcare Medical

GHM cTnI/CK-MB US Test Kit (FIA) – Quantitative Cardiac Combo Testing with 15-Minute Results, Dual Biomarker Detection, and Whole Blood/Serum/Plasma Compatibility

GHM cTnI/CK-MB US Test Kit (FIA) – Quantitative Cardiac Combo Testing with 15-Minute Results, Dual Biomarker Detection, and Whole Blood/Serum/Plasma Compatibility

Request a Quote / Contact for Price
Free worldwide shipping. Shipping included in the price.

SKU: GHM cTnI/CK-MB US
Brand: Global Healthcare Medical

Product Overview

Global Healthcare Medical GHM cTnI/CK-MB US Test Kit (FIA) is a fluorescence immunoassay (FIA) designed for the quantitative determination of Cardiac Troponin I (cTnI) and Creatine Kinase-MB (CK-MB) in human whole blood, serum, or plasma samples. The kit is intended for use with compatible POCT Analyzers, providing healthcare professionals with a reliable tool for the assessment of cardiac biomarkers in a single test.

Measurements of these blood cardiac biomarkers may serve as indicators for the assessment of myocardial injury. Cardiac troponin I is a highly specific marker of myocardial injury, while CK-MB is an isoenzyme predominantly found in cardiac muscle tissue. Together, these biomarkers provide complementary clinical value in the evaluation of patients with suspected acute coronary syndrome. The GHM cTnI/CK-MB US Test Kit delivers quantitative results for both biomarkers in just 15 minutes, supporting efficient clinical decision-making in emergency and point-of-care settings.

The kit is intended for in vitro diagnostic use and professional use only, suitable for application scenarios including emergency departments, intensive care units, clinical laboratories, and point-of-care environments. The product line is manufactured under an EN ISO 13485 certified quality management system covering in vitro diagnostic test kits and analyzers used in the detection of cardiac markers based on fluorescence immunochromatography.

Key Features & Benefits

Fluorescence Immunoassay Technology – High-Sensitivity Quantitative Detection

The GHM cTnI/CK-MB US Test Kit is based on fluorescence immunoassay technology, utilizing a sandwich immunodetection method. Fluorescence-labeled detector antibodies bind to the target proteins (cTnI and CK-MB) in the sample. The test device contains a membrane coated with specific monoclonal antibodies for each biomarker, enabling reliable and consistent quantitative detection.



Feature Benefit
Fluorescence immunoassay (FIA) High-sensitivity quantitative detection
Sandwich immunodetection method Reliable and consistent signal generation
Dual biomarker detection cTnI and CK-MB from a single sample
Quantitative determination Precise concentration results for both biomarkers

Dual Cardiac Biomarkers – cTnI and CK-MB in a Single Test

The GHM cTnI/CK-MB US Test Kit simultaneously measures two cardiac biomarkers, providing a focused cardiac panel in a single test. Cardiac troponin I is a highly specific marker of myocardial injury; CK-MB is an isoenzyme predominantly found in cardiac muscle tissue. Measurements of these blood cardiac biomarkers may serve as indicators for the assessment of myocardial injury.



Biomarker Clinical Utility Measuring Range
Cardiac Troponin I (cTnI) Highly specific marker of myocardial injury 0.1–50 ng/mL
Creatine Kinase-MB (CK-MB) Cardiac muscle isoenzyme assessment 0.3–100 ng/mL

Fast Results – 15 Minutes

The GHM cTnI/CK-MB US Test Kit provides quantitative results for both cardiac biomarkers in just 15 minutes, supporting rapid clinical decision-making and efficient patient workflow in emergency and point-of-care settings.



Feature Benefit
15-minute test time Rapid turnaround for timely clinical decisions
Point-of-care compatibility Suitable for emergency departments, ICUs, and clinical laboratories
Efficient workflow Enables immediate patient assessment
Dual results in one test Focused cardiac panel from a single sample

Wide Measuring Range – cTnI and CK-MB

The GHM cTnI/CK-MB US Test Kit supports broad measuring ranges for each biomarker, accommodating a wide variety of concentrations for comprehensive cardiac marker assessment.



Parameter Specification
Measuring Range (cTnI) 0.1–50 ng/mL
Measuring Range (CK-MB) 0.3–100 ng/mL
Specimen Whole blood (fingerstick or venous) / Serum / Plasma
Test Time 15 minutes
Operating Temperature 18–25°C
Storage Temperature 2–30°C

Flexible Sample Compatibility – Whole Blood, Serum, and Plasma

The GHM cTnI/CK-MB US Test Kit is compatible with whole blood samples obtained from fingerstick or venous collection, as well as serum and plasma samples, providing flexibility for different clinical workflows and patient sample collection preferences.



Feature Benefit
Fingerstick whole blood Convenient point-of-care sample collection
Venous whole blood Standard laboratory sample compatibility
Serum samples Standard laboratory sample compatibility
Plasma samples Alternative sample type for flexible workflows
Flexible sample collection Adaptable to different clinical settings

Clinical Performance – High Sensitivity and Specificity

The cardiac combo test kit demonstrates excellent clinical performance characteristics across both biomarkers, with high sensitivity, specificity, and accuracy.



Biomarker Sensitivity Specificity Accuracy
CK-MB 99.9% 99.6% 99.6%
Troponin I (cTnI) 98.8% 98.9% 98.8%

ISO 13485 Certified – Quality and Safety Compliance

The product line is manufactured under an EN ISO 13485 certified quality management system, demonstrating compliance with stringent international standards for the design, development, manufacture, and distribution of in vitro diagnostic test kits and analyzers.



Feature Benefit
EN ISO 13485 certification Quality management system compliance
Cardiac marker scope Certified for IVD test kits detecting cardiac markers
Quality assurance Meets high standards of quality and safety
Professional-grade Designed for healthcare professional use

Product Specifications



Specification Detail
Model / SKU GHM cTnI/CK-MB US
Product Type Cardiac Combo Test Kit (FIA)
Catalog Number VID15-03-011 (cardiac combo reference)
Intended Use Quantitative determination of Cardiac Troponin I (cTnI) and Creatine Kinase-MB (CK-MB) in human whole blood, serum, or plasma
Detection Principle Fluorescence immunoassay (FIA); sandwich immunodetection
Specimen Whole blood (fingerstick or venous) / Serum / Plasma
Test Time 15 minutes
Measuring Range (cTnI) 0.1–50 ng/mL
Measuring Range (CK-MB) 0.3–100 ng/mL
Sensitivity (cTnI) 98.8%
Specificity (cTnI) 98.9%
Accuracy (cTnI) 98.8%
Sensitivity (CK-MB) 99.9%
Specificity (CK-MB) 99.6%
Accuracy (CK-MB) 99.6%
Operating Temperature 18–25°C
Storage Temperature 2–30°C
Application Scenario Emergency department, ICU, clinical laboratory, point-of-care
Compatible Analyzers POCT Analyzers (VIM series)
Regulatory Status Manufactured under EN ISO 13485 certified quality management system
Intended User Professional healthcare use only
Package Options 25 tests/kit

Why Clinical Professionals Choose Global Healthcare Medical



Consideration GHM cTnI/CK-MB US
Fluorescence immunoassay technology High-sensitivity quantitative detection
Dual biomarker detection cTnI and CK-MB from a single sample
15-minute test time Rapid turnaround for timely decisions
Wide measuring ranges cTnI: 0.1–50 ng/mL; CK-MB: 0.3–100 ng/mL
Flexible sample types Whole blood, serum, or plasma compatibility
High clinical performance Sensitivity up to 99.9% across both biomarkers
ISO 13485 certified Quality management system compliance
Point-of-care compatible Suitable for emergency departments, ICUs, and clinical laboratories
Focused cardiac panel Supports assessment of myocardial injury

About Global Healthcare Medical

Global Healthcare Medical is dedicated to connecting healthcare providers, retailers, and distributors with high-quality medical devices designed for reliable performance. The GHM cTnI/CK-MB US is part of our professional diagnostic line, developed to support accurate, efficient, and connected point-of-care testing in clinical environments.

Our focus is on dependable performance, clear documentation, and responsive support for professional healthcare settings.

View full details